NPO-11

DRUG4 trials

Sponsors

Nihon Pharmaceutical Co., Ltd

Conditions

HealthyPatients Undergoing Gastric EndoscopyPatients Undergoing Gastrointestinal EndoscopyStomach Diseases

Phase 3

Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men

CompletedNCT00740324

Nihon Pharmaceutical Co., LtdHealthy

Start: 2008-08-31End: 2009-07-31Target: 30Updated: 2010-11-09

Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy

CompletedNCT00742599

Nihon Pharmaceutical Co., LtdPatients Undergoing Gastric Endoscopy

Start: 2008-09-30End: 2009-07-31Target: 80Updated: 2010-11-09

Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy

CompletedNCT00745459

Nihon Pharmaceutical Co., LtdStomach Diseases

Start: 2008-09-30End: 2009-08-31Target: 100Updated: 2010-11-09

Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy

CompletedNCT03263910

Nihon Pharmaceutical Co., LtdPatients Undergoing Gastrointestinal Endoscopy

Start: 2017-08-21End: 2018-08-17Updated: 2018-08-23

Related Papers

Antiperistaltic effect and safety of <scp>l</scp>‐menthol oral solution on gastric mucosa for upper gastrointestinal endoscopy in Chinese patients: Phase III, multicenter, randomized, double‐blind, placebo‐controlled study

Digestive Endoscopy2021-02-035 citations

Antiperistaltic effect and safety of L-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study.

2011-02-2629 citations